Immunotherapy Updates

A Phase II Study of T-VEC plus Pembrolizumab Immunotherapy in Patients with Sarcoma- Currently recruiting participants

Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

An Early-Stage Trial of Immunotherapy for Advanced Sarcomas

An Early-Stage Trial of Immunotherapy for Advanced Sarcomas  video by Dr. Arun Singh, 2015

Current and ongoing immunotherapy treatments hold promise  for sarcomas – in particular, these studies are looking at Leiomyosarcomas and pleomorphic sarcoma

 Dr. Bartosz B Chmielowski, MD, PHD

Leiomyosarcoma: Immunotherapy Clinical Trials  video by Dr. Bartosz Chmielowski, 2017

Breelyn A. Wilky, M.D.

PD-L1 and Immunotherapy – An overview

Web presentations on Immunotherapy for Sarcoma / Leiomyosarcoma:

Immune responses from early study of novel sarcoma vaccine

Immunotherapy with single-agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

Cancer immunotherapy webinars

The full series of monthly immunotherapy webinars from Cancer Research Institute.

Below is a video explanation of Checkpoint Inhibitors which is currently being explored for LMS.